Patient Management

2074 questions

All types2,074 Multiple choice1,048 Multiple select393 Matching221 Ordering412

A 67-year-old man presents to the clinic with excruciating pain, redness, and swelling in his right great toe that started abruptly yesterday. The pain is severe enough that he cannot tolerate the touch of a bedsheet or wear a regular shoe. His past medical history is significant for type 2 diabetes mellitus, hypertension, coronary artery disease, and stage 4 chronic kidney disease. His most recent laboratory studies from two weeks ago showed a serum creatinine of 3.2 mg/dL and an estimated glomerular filtration rate (eGFR) of 20 mL/min/1.73 m². Vital signs are temperature 37.1°C (98.8°F), blood pressure 152/90 mm Hg, and heart rate 88/min. Physical examination reveals an erythematous, warm, and exquisitely tender right first metatarsophalangeal joint. The clinical picture is highly consistent with an acute gout flare. Which of the following is the most appropriate pharmacologic intervention for this patient?

Oral prednisone

Oral indomethacin

Oral colchicine

Oral allopurinol

Intravenous ceftriaxone

Show answer & explanation

Answer: Oral prednisone

Answer

Oral prednisone

The correct intervention is oral prednisone. The management of acute gout flares relies on three primary pharmacologic options: nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or glucocorticoids (systemic or intra-articular). In patients with advanced chronic kidney disease (eGFR < 30 mL/min/1.73 m²), NSAIDs are absolutely contraindicated due to the high risk of precipitating acute renal failure. Colchicine is also heavily dependent on renal clearance and is generally avoided in severe renal impairment due to the risk of life-threatening bone marrow suppression and neuromyopathy. Therefore, systemic glucocorticoids such as oral prednisone are the safest and most appropriate first-line choice for acute flare stabilization in this patient.

Step-by-Step Solution

Identify the primary clinical problem requiring acute management.

The patient is experiencing an acute gout flare in the right first metatarsophalangeal joint (podagra).

The history of abrupt, severe monoarticular joint pain with erythema and swelling in the great toe is the classic presentation of acute gout.

Evaluate patient-specific comorbidities that influence pharmacologic choices.

The patient has stage 4 chronic kidney disease with an eGFR of 20 mL/min/1.73 m².

Standard first-line treatments for gout must be filtered through the patient's renal function to avoid severe iatrogenic complications.

Select the safest and most effective first-line anti-inflammatory medication.

Oral prednisone (or intra-articular glucocorticoids) is chosen.

Glucocorticoids do not rely on renal clearance and do not cause acute nephrotoxicity, making them the safest choice when NSAIDs and colchicine are contraindicated by severe renal impairment.

Key Concept

Management of acute gout flares in patients with underlying severe chronic kidney disease.

Question 482Question →

During a clinic visit, a physician evaluates a 68-year-old man who complains of severe right foot pain that frequently awakens him from sleep. The patient notes that hanging his foot over the edge of the mattress partially alleviates the discomfort. His medical history is significant for long-standing type 2 diabetes mellitus complicated by peripheral neuropathy, hypertension, and stage 3 chronic kidney disease. Vital signs are within normal limits. Physical examination reveals a 1.5-cm dry, blackened eschar on the distal tip of the right great toe with minimal surrounding erythema. The right foot feels cool to the touch, and both the dorsalis pedis and posterior tibial pulses are nonpalpable. The physician performs an in-office ankle-brachial index (ABI) measurement to evaluate for peripheral arterial disease. The right ABI is calculated to be 1.45. Which of the following is the most appropriate next step in the diagnostic workup?

Measurement of toe-brachial index

Computed tomography angiography of the lower extremities

Arterial duplex ultrasonography of the lower extremities

Invasive peripheral catheter angiography

Exercise treadmill testing with repeat ankle-brachial index

Show answer & explanation

Answer: Measurement of toe-brachial index

Answer

Measurement of toe-brachial index is the required next step when the ABI is non-diagnostic (>1.40) to establish the physiologic presence of peripheral arterial disease.

The correct sequence for evaluating peripheral arterial disease begins with an ankle-brachial index (ABI). Normal values are 0.90 to 1.30. A value >1.40 indicates medial artery calcification (Mönckeberg sclerosis), making the vessels noncompressible. This is a common finding in patients with diabetes mellitus and chronic kidney disease. When the ABI is uninterpretable in a patient with clear signs of critical limb ischemia (rest pain, tissue loss), the most appropriate next step is to obtain a toe-brachial index (TBI). The digital arteries are typically spared from calcification, allowing for accurate assessment of distal perfusion.

Step-by-Step Solution

Identify the clinical syndrome presented by the patient.

The patient has rest pain and a non-healing ulcer (eschar) on the great toe, which indicates critical limb ischemia.

Recognizing the severity of the disease establishes the urgent need for accurate perfusion assessment.

Interpret the results of the initial diagnostic test (ABI).

The calculated ABI is 1.45.

An ABI greater than 1.40 indicates severely calcified and noncompressible leg arteries, a common finding in long-standing diabetes or end-stage renal disease, rendering the ABI non-diagnostic.

Determine the appropriate sequential step according to vascular testing guidelines.

Measurement of the toe-brachial index (TBI) should be performed.

Digital arteries in the toes are rarely affected by medial calcification, allowing for an accurate measurement of perfusion pressures when large vessel compression fails.

Key Concept

In patients with suspected peripheral arterial disease whose initial ankle-brachial index (ABI) is abnormally high (>1.40) due to noncompressible calcified vessels, the next step in the diagnostic sequence is to measure the toe-brachial index (TBI).

Question 483Question →

During morning rounds in the cardiac intensive care unit, the medical team reviews the chart of a 61-year-old female who was admitted five days ago for an acute anterior myocardial infarction complicated by a left ventricular mural thrombus. She has been receiving a continuous intravenous infusion of unfractionated heparin since admission. Her daily laboratory results show a platelet count of $88,000/\text{mm}^3$ , a precipitous decline from her baseline of $245,000/\text{mm}^3$ upon admission. On physical examination, she reports new-onset right lower extremity pain, and subsequent compression ultrasonography reveals an acute deep vein thrombosis in the right popliteal vein. Suspecting heparin-induced thrombocytopenia (HIT), the attending physician immediately discontinues the heparin infusion and initiates a continuous infusion of argatroban. The team discusses the long-term plan to discharge the patient on oral warfarin therapy.

Which of the following is the most appropriate protocol for monitoring this patient's recovery and transitioning her to the planned oral anticoagulant?

Postpone the initiation of warfarin until the platelet count reaches at least

150,000/\text{mm}^3

, then overlap both medications for a minimum of 5 days.

Initiate warfarin concurrently with argatroban today and discontinue argatroban once the international normalized ratio is therapeutic for 48 hours.

Discontinue argatroban once the platelet count normalizes, and immediately begin warfarin monotherapy to minimize the risk of bleeding.

Transition the patient to a therapeutic dose of subcutaneous enoxaparin while awaiting platelet recovery, then initiate warfarin.

Order a serotonin release assay; if the result is negative, resume unfractionated heparin and initiate a standard warfarin bridge.

Show answer & explanation

Answer: Postpone the initiation of warfarin until the platelet count reaches at least $150,000/\text{mm}^3$ , then overlap both medications for a minimum of 5 days.

Answer

Postpone the initiation of warfarin until the platelet count reaches at least

150,000/\text{mm}^3

, then overlap both medications for a minimum of 5 days.

The correct protocol for transitioning a patient with heparin-induced thrombocytopenia (HIT) to warfarin requires rigorous monitoring of the platelet count. Because warfarin rapidly depletes protein C (a natural anticoagulant) faster than it depletes prothrombin, it initially creates a transient hypercoagulable state. In a patient with active HIT, this can precipitate severe microvascular thrombosis, leading to warfarin-induced skin necrosis and venous limb gangrene. To prevent this, warfarin therapy must be postponed until the acute hypercoagulable state of HIT has resolved, which is indicated by a recovery of the platelet count to at least

150,000/\text{mm}^3

(or the patient's baseline). Once this threshold is met, warfarin can be initiated, but it must be overlapped with a non-heparin anticoagulant (e.g., argatroban) for a minimum of 5 days AND until the international normalized ratio (INR) has been within the therapeutic range for at least 24 to 48 hours.

Step-by-Step Solution

Analyze the clinical presentation.

The patient has a

>50\%

drop in platelets and a new thrombosis on day 5 of heparin therapy, indicating a high probability of heparin-induced thrombocytopenia (HIT).

Recognizing the high pre-test probability (high 4T score) dictates immediate cessation of heparin and initiation of a non-heparin anticoagulant.

Evaluate the criteria for transitioning to warfarin.

Warfarin cannot be started during the acute phase of HIT. Platelets must recover to a safe threshold.

Warfarin causes a rapid decline in Protein C, a natural anticoagulant. In the setting of active HIT, this transient hypercoagulable state can lead to severe complications like venous limb gangrene.

Apply the standard bridging protocol for HIT recovery.

Wait until the platelet count is

\ge 150,000/\text{mm}^3

. Then, start warfarin and overlap it with the direct thrombin inhibitor (argatroban) for at least 5 days AND until the INR is therapeutic for 24-48 hours.

This specific sequence ensures the patient remains fully anticoagulated while protein C levels stabilize alongside the vitamin K-dependent procoagulant factors (II, VII, IX, X).

Key Concept

Monitoring and transitioning to oral anticoagulation in Heparin-Induced Thrombocytopenia (HIT)

Estimated Time:1m 30s

Question 484Question →

Match each patient presenting with chest pain to the most appropriate next step in diagnostic test sequencing, based on their individual risk factors and comorbidities.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The optimal test sequencing depends on baseline electrocardiogram findings, the ability to exercise, and specific comorbidities: standard exercise electrocardiography for patients with a normal baseline who are able to exercise; vasodilator myocardial perfusion imaging for those with a left bundle branch block; dobutamine stress echocardiography for those with severe lung disease who cannot exercise; and direct invasive angiography for those with refractory typical angina.

Each patient's clinical profile dictates a specific diagnostic pathway. Standard exercise electrocardiography is the most appropriate, cost-effective initial test for a low-to-intermediate risk patient who can exercise and has a normal resting electrocardiogram. If a patient has an LBBB, exercise increases the heart rate and causes asynchronous septal contraction, mimicking ischemia on perfusion scans; therefore, pharmacologic vasodilation is strictly indicated. For a patient unable to exercise, pharmacologic stress is required, but vasodilators (e.g., adenosine) are contraindicated in severe COPD due to bronchospasm risk, making dobutamine stress echocardiography the safest choice. Finally, a patient with refractory typical angina on maximal therapy requires definitive anatomical evaluation with invasive coronary angiography.

Step-by-Step Solution

Assess the patient's pre-test probability for coronary artery disease and current symptom control.

Identifies high-risk patients (e.g., refractory symptoms on maximal therapy) who require direct invasive angiography, bypassing non-invasive testing.

Non-invasive testing in highly symptomatic, high-risk patients delays necessary revascularization and provides little additional diagnostic utility.

Determine the patient's ability to achieve adequate physical exertion (e.g., walking on a treadmill).

Separates candidates for exercise stress testing from those who require pharmacologic stress testing.

Exercise is the preferred physiologic stressor, but inability to reach target heart rate renders the test nondiagnostic.

Evaluate the baseline electrocardiogram for abnormalities that preclude the interpretation of stress-induced ischemic changes.

Identifies conditions like left bundle branch block (LBBB) or ventricular pacing.

Exercise with an LBBB increases the heart rate and causes asynchronous septal contraction, mimicking ischemia on perfusion scans. Pharmacologic vasodilation avoids this artifact.

Review patient comorbidities for specific contraindications to pharmacologic agents.

Identifies relative or absolute contraindications, such as severe reactive airway disease (COPD/asthma).

Vasodilator agents like adenosine can trigger severe bronchospasm. In such cases, an inotrope/chronotrope like dobutamine is the required alternative.

Key Concept

Selection of the appropriate diagnostic modality for coronary artery disease relies on analyzing the patient's baseline electrocardiogram, functional exercise capacity, and specific medical contraindications.

Question 485Question →

A 48-year-old man is evaluated in the hospital for a 3-day history of fever, pleuritic chest pain, and hemoptysis. He underwent a deceased-donor renal transplant 4 months ago for end-stage renal disease secondary to IgA nephropathy. His current medications include tacrolimus, mycophenolate mofetil, and prednisone. Temperature is $38.4^\circ\text{C}$ ( $101.1^\circ\text{F}$ ), blood pressure is $130/80\text{ mmHg}$ , pulse is $98/\text{min}$ , and respiratory rate is $18/\text{min}$ . Laboratory studies show a serum creatinine of $1.4\text{ mg/dL}$ . A CT scan of the chest demonstrates a right upper lobe cavitary lesion with a surrounding halo of ground-glass opacity. Serum galactomannan assay is prominently elevated. The attending physician plans to initiate the first-line targeted antimicrobial therapy for this patient's opportunistic infection. Which of the following is the most appropriate concurrent pharmacologic management step?

Decrease the current dose of tacrolimus

Replace tacrolimus with cyclosporine

Initiate intravenous fluconazole instead of the planned therapy

Initiate liposomal amphotericin B instead of the planned therapy

Maintain the current tacrolimus dose and recheck serum creatinine in 14 days

Show answer & explanation

Answer: Decrease the current dose of tacrolimus

Answer

Decrease the current dose of tacrolimus

The patient's clinical presentation, chest imaging showing a halo sign, and a positive serum galactomannan assay confirm the diagnosis of invasive pulmonary aspergillosis. The gold-standard treatment for this opportunistic infection is voriconazole. A critical pharmacologic principle in transplant medicine is managing the predictable drug-drug interaction between triazole antifungals and calcineurin inhibitors. Voriconazole strongly inhibits the cytochrome P450 3A4 (CYP3A4) enzyme. Tacrolimus is a narrow-therapeutic-index medication that relies heavily on CYP3A4 for its metabolism. Initiating voriconazole without adjusting the tacrolimus dose will rapidly cause toxic serum concentrations of tacrolimus, leading to acute kidney injury and neurotoxicity. Therefore, the most appropriate concurrent pharmacologic intervention is to preemptively decrease the tacrolimus dose (often by 30% to 50%) and to rigorously monitor tacrolimus trough levels over the subsequent days.

Step-by-Step Solution

Diagnose the opportunistic infection based on clinical and radiographic findings.

The triad of fever, pleuritic chest pain, and hemoptysis in a transplant patient, combined with a cavitary lesion showing a halo sign and a positive galactomannan assay, indicates invasive pulmonary aspergillosis.

Accurate diagnosis is required to anticipate the correct antimicrobial therapy.

Identify the standard first-line pharmacotherapy for the diagnosed infection.

Intravenous voriconazole is the primary targeted therapy for invasive aspergillosis.

The planned therapy acts as the trigger for potential drug interactions.

Analyze the pharmacokinetic properties of the intended antimicrobial.

Voriconazole is widely known as a potent inhibitor of the hepatic cytochrome P450 3A4 (CYP3A4) enzyme system.

Recognizing enzyme inhibition is critical when managing polypharmacy in complex patients.

Assess the patient's current medication list for significant interactions.

Tacrolimus is a narrow-therapeutic-index calcineurin inhibitor that is almost exclusively metabolized by CYP3A4.

Identifying the vulnerable substrate prevents iatrogenic toxicity.

Determine the necessary concurrent pharmacologic intervention.

The tacrolimus dose must be empirically decreased (usually by one-third to one-half) concurrently with the initiation of voriconazole, followed by close monitoring of trough levels.

Preemptive dose reduction prevents dangerous accumulations of tacrolimus that lead to acute nephrotoxicity.

Key Concept

Management of potent CYP3A4-mediated drug interactions, specifically preemptive dose reduction of calcineurin inhibitors (like tacrolimus) when initiating triazole antifungals.

Question 486Question →

A $62$ -year-old man is evaluated on the medical ward for new-onset right calf swelling and pain. He was admitted $6$ days ago for severe community-acquired pneumonia and was started on intravenous antibiotics and subcutaneous unfractionated heparin for deep vein thrombosis prophylaxis. Vital signs are temperature $37.2^\circ\text{C}$ ( $99.0^\circ\text{F}$ ), blood pressure $128/82\text{ mmHg}$ , pulse $88/\text{min}$ , and respirations $16/\text{min}$ . Physical examination reveals a swollen, erythematous, and tender right calf. A lower extremity venous duplex ultrasound confirms a proximal deep vein thrombosis in the right popliteal vein. Laboratory studies from today are compared to admission values:

Laboratory Test	Current Value	Admission Value
Platelet count	$55,000/\text{mm}^3$	$240,000/\text{mm}^3$
Hemoglobin	$13.5\text{ g/dL}$	$13.8\text{ g/dL}$
Serum creatinine	$1.1\text{ mg/dL}$	$1.0\text{ mg/dL}$

Which of the following is the most appropriate pharmacologic intervention for this patient?

Intravenous argatroban

Subcutaneous enoxaparin

Oral warfarin

Intravenous platelet transfusion

Discontinuation of unfractionated heparin without alternative anticoagulation

Show answer & explanation

Answer: Intravenous argatroban

Answer

Intravenous argatroban

The correct answer is intravenous argatroban. This patient has developed Heparin-Induced Thrombocytopenia (HIT) with thrombosis, specifically a new right lower extremity deep vein thrombosis. HIT is an immune-mediated adverse drug reaction characterized by a platelet count drop of greater than 50% occurring 5-14 days after heparin exposure. The immediate management of HIT requires the absolute discontinuation of all heparin products (including flushes) and the immediate initiation of a non-heparin anticoagulant. Direct thrombin inhibitors (such as argatroban or bivalirudin) or the factor Xa inhibitor fondaparinux are the preferred pharmacologic interventions to manage the highly prothrombotic state associated with HIT.

Step-by-Step Solution

Calculate the magnitude and timing of the platelet drop.

The platelet count has dropped by >50% (from 240,000 to 55,000) exactly 6 days after the initiation of unfractionated heparin.

This timeline and magnitude highly suggest Heparin-Induced Thrombocytopenia (HIT).

Correlate laboratory findings with clinical presentation.

The patient has developed a new deep vein thrombosis concurrently with the drop in platelets.

This confirms a highly prothrombotic state characteristic of HIT with thrombosis (HITT).

Determine the necessary pharmacologic intervention.

All heparin products must be immediately discontinued, and a non-heparin anticoagulant (like argatroban) must be initiated.

Stopping heparin alone is insufficient because the patient has an active thrombosis and an ongoing hypercoagulable state.

Key Concept

Management of Heparin-Induced Thrombocytopenia (HIT) with thrombosis requires immediate cessation of all heparin products and initiation of a non-heparin anticoagulant (e.g., argatroban, bivalirudin, or fondaparinux).

Question 487Question →

A 72-year-old man comes to the clinic for a routine follow-up. He has a history of a mechanical aortic valve replacement performed 4 years ago. He is maintained on a stable daily dose of warfarin, and his international normalized ratio (INR) has consistently remained within the target therapeutic range of 2.5 to 3.5 for the past year. Two weeks ago, the patient was diagnosed with highly symptomatic paroxysmal atrial fibrillation and was started on amiodarone by his cardiologist. He reports no bleeding, bruising, dizziness, or palpitations today. His vital signs are within normal limits, and physical examination is unremarkable. Which of the following is the most appropriate next step in the monitoring and management of this patient's pharmacotherapy?

Continue the current medication regimen and check the international normalized ratio at the next routine 3-month visit

Measure the prothrombin time/international normalized ratio and preemptively decrease the warfarin dose

Discontinue warfarin and initiate a direct oral anticoagulant such as rivaroxaban

Monitor the activated partial thromboplastin time to guide necessary adjustments to the warfarin dose

Order a non-contrast computed tomography scan of the head to screen for subclinical intracranial hemorrhage

Show answer & explanation

Answer: Measure the prothrombin time/international normalized ratio and preemptively decrease the warfarin dose

Answer

Measure the prothrombin time/international normalized ratio and preemptively decrease the warfarin dose.

Amiodarone is a well-known, potent inhibitor of several cytochrome P450 enzymes, most notably CYP2C9. Warfarin is administered as a racemic mixture, and its more active S-enantiomer is primarily metabolized by CYP2C9. When amiodarone is added to a stable warfarin regimen, it severely decreases warfarin clearance, leading to elevated serum warfarin concentrations, a dramatically prolonged prothrombin time (PT)/international normalized ratio (INR), and an increased risk of severe bleeding. Standard medical management requires immediately checking the INR upon amiodarone initiation and preemptively reducing the warfarin dose by 25% to 50%, followed by close, frequent laboratory monitoring until a new steady state is achieved.

Step-by-Step Solution

Identify the patient's current active medications and conditions.

The patient is taking warfarin for a mechanical aortic valve and recently started amiodarone for atrial fibrillation.

Establishing the medication list is the first step in identifying potential drug-drug interactions.

Analyze the pharmacokinetic relationship between the newly added drug and the existing regimen.

Amiodarone is a potent inhibitor of the cytochrome P450 enzyme CYP2C9, which is primarily responsible for the metabolism of warfarin.

Understanding enzyme inhibition is critical to predicting changes in serum drug levels.

Determine the necessary clinical intervention based on the anticipated physiologic effect.

Because warfarin clearance will be reduced, serum levels will rise, leading to a supratherapeutic INR. The correct action is to immediately check the INR and empirically reduce the warfarin dose.

Proactive dose reduction prevents severe hemorrhagic complications associated with supratherapeutic anticoagulation.

Key Concept

When amiodarone is initiated in a patient taking warfarin, the amiodarone inhibits CYP2C9-mediated warfarin metabolism. The physician must monitor the prothrombin time/INR closely and empirically reduce the warfarin dose (typically by 25% to 50%) to prevent dangerous bleeding.

Question 488Question →

An adult patient is undergoing treatment in the intensive care unit for diabetic ketoacidosis. Initial therapy with a continuous intravenous insulin infusion and fluid resuscitation has been established. Arrange the following monitoring, treatment adjustment, and de-escalation steps in the standard chronological sequence required to safely resolve the episode and transition the patient to a subcutaneous maintenance regimen.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: establish frequent biochemical monitoring, add dextrose when glucose reaches 200 mg/dL, confirm biochemical resolution via the anion gap, administer subcutaneous basal insulin, and finally discontinue the intravenous insulin infusion 1 to 2 hours later.

This sequence represents the widely tested, universal protocol for managing and safely de-escalating therapy in diabetic ketoacidosis. Frequent monitoring ensures safety, adding dextrose allows insulin to run until the gap closes, checking the gap confirms resolution, and overlapping the subcutaneous dose prevents rebound.

Step-by-Step Solution

Initiate frequent serial monitoring (hourly glucose, Q2-Q4H electrolytes).

Real-time tracking of glucose decline and potassium shifts.

Continuous insulin infusions cause rapid metabolic shifts; close monitoring dictates the pacing of fluid and electrolyte replacement.

Add dextrose to intravenous fluids when glucose reaches 200 mg/dL.

Maintained euglycemia while hyperketonemia is still being treated.

Blood glucose typically normalizes faster than ketones clear. Dextrose allows insulin to continue running without causing hypoglycemia.

Check for closure of the anion gap (<12 mEq/L) and improvement in pH.

Objective documentation that the underlying ketoacidosis has resolved.

You cannot transition a patient off an insulin drip safely until the primary pathophysiology (ketone production) is halted.

Administer subcutaneous basal insulin.

Creation of a subcutaneous insulin depot.

Subcutaneous insulin takes time to absorb and reach steady-state. It must be given while the IV infusion is still providing coverage.

Stop the intravenous insulin infusion 1 to 2 hours later.

Successful transition to maintenance therapy.

Intravenous regular insulin has a half-life of mere minutes. Stopping it immediately without overlap would leave the patient with zero active insulin, triggering rapid rebound ketoacidosis.

Key Concept

The standard protocol for diabetic ketoacidosis resolution requires adding dextrose before stopping insulin, confirming anion gap closure, and ensuring an overlap period between subcutaneous insulin administration and intravenous insulin discontinuation.

Question 489Question →

A 28-year-old woman is evaluated in the emergency department for a 2-day history of right-sided back pain, fever, and chills. She also reports severe nausea and has vomited four times over the past 6 hours. She has no significant past medical history and takes no daily medications.

Temperature is 39.0°C (102.2°F), blood pressure is 115/75 mmHg, pulse is 112/min, and respirations are 18/min. Physical examination reveals marked right-sided costovertebral angle tenderness. The patient appears flushed and actively vomits a small amount of bilious fluid during the examination.

Laboratory results:
Leukocyte count: 16,500/mm³
Serum creatinine: 0.8 mg/dL
Urine pregnancy test: Negative
Urinalysis: Positive for nitrites and leukocyte esterase; >50 WBCs/hpf

The patient is given 1 L of intravenous normal saline, intravenous ceftriaxone, and intravenous ondansetron. Two hours later, her temperature is 38.3°C (100.9°F), pulse is 95/min, and blood pressure is 118/78 mmHg. The nurse provides her with a small cup of water, which she immediately vomits.

Based on these findings, which of the following is the most appropriate disposition for this patient?

Admission to the general medical ward

Discharge home with a prescription for oral ciprofloxacin

Discharge home with arrangements for daily outpatient intravenous ceftriaxone

Admission to the intensive care unit

Transfer to a skilled nursing facility

Show answer & explanation

Answer: Admission to the general medical ward

Answer

Admission to the general medical ward

This patient has acute pyelonephritis and demonstrates persistent intractable vomiting despite the administration of intravenous antiemetics. While many younger, healthy patients with pyelonephritis can be safely treated in the outpatient setting, clear indications for inpatient admission include an inability to tolerate oral hydration or medications, hemodynamic instability, severe pain, or complications such as urinary obstruction. Because she failed an oral fluid challenge, she requires ongoing intravenous maintenance fluids and intravenous antibiotics to prevent severe hypovolemia and ensure adequate treatment. This requires an inpatient admission to a general medical ward.

Step-by-Step Solution

Diagnose the patient's acute condition based on clinical and laboratory findings.

The patient has acute pyelonephritis, supported by fever, costovertebral angle tenderness, leukocytosis, and a positive urinalysis.

Establishing the correct infectious diagnosis determines the baseline treatment requirements (antibiotics and hydration).

Assess the patient's severity and ability to tolerate outpatient treatment.

The patient is hemodynamically stable but has intractable vomiting, failing a direct oral challenge in the emergency department.

Disposition decisions for pyelonephritis hinge largely on the patient's ability to maintain hydration and absorb oral medications at home.

Determine the most appropriate care setting based on the assessment.

Admission to the general medical ward is required for continuous intravenous hydration, intravenous antibiotics, and close monitoring.

An inability to tolerate oral intake mandates an inpatient level of care until the patient improves and can be safely transitioned to oral therapy.

Key Concept

Hospital admission criteria for acute pyelonephritis including intractable vomiting and inability to tolerate oral hydration.

Question 490Question →

A 71-year-old woman is transported from a skilled nursing facility to the emergency department due to a sudden decline in responsiveness over the past six hours. The accompanying documentation notes that she had foul-smelling urine earlier in the shift. Her past medical history includes advanced vascular dementia and type 2 diabetes mellitus. On presentation, she is lethargic, muttering incomprehensibly, and opens her eyes only to painful stimuli. Vital signs reveal a blood pressure of $72/40 \text{ mm Hg}$ , a heart rate of $134/\text{min}$ , a respiratory rate of $26/\text{min}$ , and a core temperature of $39.5^\circ\text{C}$ ( $103.1^\circ\text{F}$ ). Oxygen saturation is $95\%$ on ambient air. Physical examination demonstrates warm, flushed extremities with bounding peripheral pulses. A chronic indwelling urinary catheter is in place, draining turbid, dark fluid. Which of the following interventions should be ordered SIMULTANEOUSLY as the most appropriate initial steps in management? (Select all that apply)

Select all that apply

Rapid intravenous infusion of a balanced crystalloid solution

Non-contrast computed tomography of the head

Procurement of peripheral blood and urine cultures

Intravenous administration of broad-spectrum antibiotics

Immediate transfer to the intensive care unit

Show answer & explanation

Answer: Rapid intravenous infusion of a balanced crystalloid solution; Procurement of peripheral blood and urine cultures; Intravenous administration of broad-spectrum antibiotics

Answer

The most appropriate simultaneous initial steps are the rapid intravenous infusion of a balanced crystalloid solution, procurement of peripheral blood and urine cultures, and intravenous administration of broad-spectrum antibiotics.

This patient is presenting with severe sepsis progressing to septic shock, evidenced by profound hypotension, hyperpyrexia, tachycardia, and altered mental status secondary to a likely catheter-associated urinary tract infection. The standard of care for septic shock requires an immediate, simultaneous bundle of interventions within the first hour of recognition. This bundle includes measuring lactate, obtaining appropriate cultures (blood and urine), administering empiric broad-spectrum antibiotics, and rapidly infusing

30 \text{ mL/kg}

of crystalloid fluids. These steps address the underlying distributive shock and begin treating the systemic infection concurrently.

Step-by-Step Solution

Assess the patient's primary physiologic derangement.

The patient exhibits severe hypotension, tachycardia, tachypnea, high fever, and altered mental status with a suspected urinary source.

Identifying the clinical syndrome as decompensated septic shock dictates the urgency and nature of the required interventions.

Determine the priority of care in undifferentiated shock.

Immediate stabilization of perfusion and treatment of the underlying systemic infection take absolute precedence over finding secondary diagnoses.

Delaying resuscitation in septic shock exponentially increases morbidity and mortality.

Select the appropriate simultaneous orders according to the sepsis bundle guidelines.

Orders are placed simultaneously for blood and urine cultures, broad-spectrum antibiotics, and a

30 \text{ mL/kg}

rapid crystalloid fluid bolus.

These interventions form the critical 'first-hour' stabilization bundle and must be executed in parallel without waiting for disposition or advanced imaging.

Key Concept

In patients presenting with septic shock, initial stabilization requires the simultaneous execution of a resuscitation bundle that includes drawing cultures, administering broad-spectrum antibiotics, and initiating aggressive fluid resuscitation.

Question 491Question →

A 31-year-old woman is brought to the emergency department after sustaining a stab wound to the left lower chest. On arrival, she is pale, diaphoretic, and confused. Her blood pressure is 72/40 mm Hg, pulse is 142/min, and respirations are 32/min. Oxygen saturation is 92% on 15 L/min of oxygen via a non-rebreather mask. Primary survey reveals a 3-cm penetrating wound in the left sixth intercostal space at the midaxillary line. Breath sounds are markedly decreased on the left. The trachea is midline, and the jugular veins are flat. Bedside extended focused assessment with sonography for trauma (eFAST) reveals a large accumulation of fluid in the left hemithorax, with no pericardial effusion or free intraperitoneal fluid. Two large-bore peripheral intravenous lines are established.

Which of the following are the most appropriate simultaneous next steps in the initial stabilization of this patient? (Select 2)

Select all that apply

Activation of the massive transfusion protocol

Insertion of a left-sided thoracostomy tube

Computed tomography angiography of the chest

Administration of a 2-liter intravenous crystalloid bolus

Placement of a central venous catheter for hemodynamic monitoring

Show answer & explanation

Answer: Activation of the massive transfusion protocol; Insertion of a left-sided thoracostomy tube

Answer

The most appropriate simultaneous next steps are activation of the massive transfusion protocol and insertion of a left-sided thoracostomy tube.

This patient presents with a massive hemothorax and Class IV hemorrhagic shock following a penetrating chest injury. Her confusion, severe hypotension, and profound tachycardia mandate immediate life-saving interventions. The management of an unstable massive hemothorax requires two simultaneous actions: decompression of the pleural space and volume resuscitation. Insertion of a thoracostomy tube (chest tube) serves both diagnostic and therapeutic purposes; it evacuates the accumulated blood, allowing the lung to re-expand and improve ventilation, while also providing a means to monitor the rate of ongoing hemorrhage (which dictates the need for an emergency thoracotomy). Concurrently, because the patient is in profound hemorrhagic shock, resuscitation must be initiated with a massive transfusion protocol (MTP). MTP provides packed red blood cells, fresh frozen plasma, and platelets in a balanced ratio (often 1:1:1), which restores intravascular volume and oxygen-carrying capacity while preventing the dilutional coagulopathy that occurs with crystalloid administration.

Step-by-Step Solution

Analyze the patient's hemodynamic status and clinical signs.

The patient is in Class IV hemorrhagic shock (confusion, pulse >140/min, severe hypotension) with a penetrating chest injury.

Identifying the severity of shock dictates the urgency and type of fluid resuscitation required.

Correlate physical examination findings with the eFAST results.

Decreased breath sounds on the left, flat neck veins, and fluid in the left hemithorax on ultrasound confirm a massive left hemothorax.

Establishing the source of bleeding and respiratory compromise guides the specific physical intervention.

Determine the necessary immediate stabilization interventions.

Simultaneous pleural decompression (tube thoracostomy) and balanced damage-control resuscitation (massive transfusion protocol) are required.

Tube thoracostomy treats the respiratory compromise and measures bleeding, while the massive transfusion protocol treats the hemorrhagic shock without causing dilutional coagulopathy.

Key Concept

In unstable patients with a massive hemothorax, initial stabilization requires simultaneous pleural decompression via tube thoracostomy and damage-control resuscitation using a massive transfusion protocol.

Question 492Question →

A 48-year-old woman is evaluated in the intensive care unit for progressive confusion, right upper quadrant abdominal pain, and high fever over the past 24 hours. Her medical history is significant for a Roux-en-Y gastric bypass performed 3 years ago for severe obesity, and an uncomplicated laparoscopic cholecystectomy 10 years ago. She has no known allergies. Her temperature is $39.4^\circ\text{C}$ ( $102.9^\circ\text{F}$ ), blood pressure is $82/50 \text{ mm Hg}$ despite the rapid administration of 3 L of intravenous crystalloid solution, heart rate is 128/min, and respiratory rate is 24/min. She has been started on a norepinephrine infusion. Physical examination reveals scleral icterus and marked tenderness in the right upper quadrant without rebound or guarding. She is lethargic and oriented only to person. Laboratory studies show:

- Leukocyte count: $22,000/\text{mm}^3$ (85% neutrophils, 10% bands)
- Platelet count: $95,000/\text{mm}^3$
- Total bilirubin: $8.4 \text{ mg/dL}$
- Direct bilirubin: $6.2 \text{ mg/dL}$
- Alkaline phosphatase: $520 \text{ U/L}$
- Aspartate aminotransferase (AST): $145 \text{ U/L}$
- Alanine aminotransferase (ALT): $130 \text{ U/L}$
- International normalized ratio (INR): $1.6$

A right upper quadrant ultrasound reveals a dilated common bile duct measuring 14 mm with internal echogenic debris and a suspected calculus in the distal aspect. The patient is receiving empiric intravenous broad-spectrum antibiotics. Which of the following is the most appropriate next step in the procedural management of this patient?

Percutaneous transhepatic biliary drainage

Endoscopic retrograde cholangiopancreatography

Magnetic resonance cholangiopancreatography

Open common bile duct exploration

Transfusion of fresh frozen plasma and delayed intervention

Show answer & explanation

Answer: Percutaneous transhepatic biliary drainage

Answer

The most appropriate next step is percutaneous transhepatic biliary drainage.

The patient has severe acute cholangitis complicated by septic shock (Reynolds' pentad). The definitive treatment is urgent biliary decompression. Because she has a history of a Roux-en-Y gastric bypass, the major duodenal papilla is excluded from the alimentary tract, making standard endoscopic retrograde cholangiopancreatography (ERCP) anatomically impossible. In a hemodynamically unstable patient, percutaneous transhepatic biliary drainage (PTBD) is the gold standard for rapid and minimally invasive decompression. Complex alternatives like laparoscopy-assisted ERCP (LA-ERCP) or EUS-directed transgastric ERCP (EDGE) are generally reserved for stable patients due to the time and physiological stress involved.

Step-by-Step Solution

Analyze the clinical presentation.

The patient presents with Charcot's triad (fever, jaundice, RUQ pain) and Reynolds' pentad (plus shock and altered mental status), indicating severe acute toxic cholangitis.

To establish the primary life-threatening diagnosis requiring immediate source control.

Evaluate hemodynamic stability.

The patient is in septic shock and requires a norepinephrine infusion despite fluid resuscitation.

Hemodynamic instability dictates the choice and urgency of the procedural intervention, favoring minimally invasive approaches.

Assess anatomical constraints based on surgical history.

A history of Roux-en-Y gastric bypass (RYGB) means the stomach is divided, and the biliary tree cannot be accessed via the standard transoral route.

To determine the technical feasibility of standard endoscopic interventions like ERCP.

Select the most appropriate procedural intervention.

Percutaneous transhepatic biliary drainage (PTBD) is chosen over surgical exploration or advanced endoscopic techniques.

PTBD provides rapid, life-saving biliary decompression in an unstable patient with altered foregut anatomy.

Key Concept

In patients with severe acute cholangitis and altered foregut anatomy (e.g., Roux-en-Y gastric bypass) who are hemodynamically unstable, percutaneous transhepatic biliary drainage (PTBD) is the preferred method for emergent biliary decompression.

Question 493Question →

A 45-year-old woman is admitted to the intensive care unit with septic shock requiring vasopressor support. The physician prepares to place a right internal jugular central venous catheter using the Seldinger technique. After proper sterile preparation, draping, and administration of local anesthesia, arrange the following steps in the correct chronological sequence for inserting the catheter.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for the Seldinger technique is: needle puncture, guidewire insertion, tract dilation, and finally catheter placement.

The Seldinger technique universally requires initial needle puncture to locate and enter the vessel. This is followed immediately by guidewire insertion through the needle to secure the tract. The needle is then exchanged for a dilator over the wire to widen the tissue path. Finally, the dilator is removed and the catheter is passed over the wire, after which the wire is carefully extracted.

Step-by-Step Solution

Introducer Needle Insertion

Initial access to the vessel is established, confirmed by venous blood return.

Provides a conduit to introduce the guidewire into the venous lumen.

Guidewire Advancement

The guidewire is secured within the vein.

Maintains the track into the vessel after the initial needle is removed.

Tissue Dilation

The subcutaneous tract is widened.

Creates a path large enough to accommodate the central venous catheter without causing excessive tissue trauma.

Catheter Insertion

The central venous catheter is successfully placed in the target vessel.

Allows for the delivery of critical medications, such as vasopressors, while safely removing the guidewire.

Key Concept

The Seldinger technique is the foundational method for safe vascular access, utilizing an initial needle puncture followed by a guidewire to maintain access while a tract is dilated for ultimate catheter insertion.

Question 494Question →

Evaluate the following hospitalized patients who are nearing medical stability on the acute care service. Match each patient's clinical presentation and functional status with the most appropriate post-acute care disposition setting.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct dispositions are: the patient with the spinal cord injury to an IRF, the patient requiring ventilator weaning to an LTACH, the deconditioned patient needing IV antibiotics to an SNF, the patient with refractory cancer symptoms to Inpatient Hospice, and the patient with new heart failure to Home with Home Health services.

Appropriate disposition requires matching the patient's medical acuity, functional capacity, and ongoing nursing or therapy needs with the regulatory capabilities of the receiving facility. IRFs are reserved for intensive rehab (>3 hours/day). LTACHs manage extended critical care needs like ventilator weaning. SNFs provide subacute rehab and skilled nursing for those unable to tolerate intensive therapy. Inpatient hospice provides acute symptom control for terminal illnesses. Home health provides intermittent skilled care at a patient's residence.

Step-by-Step Solution

Evaluate the 42-year-old patient with SCI.

Matches to Inpatient Rehabilitation Facility (IRF).

Medicare guidelines require IRF patients to tolerate at least 3 hours of intensive therapy per day, which she can achieve.

Evaluate the 64-year-old patient with ARDS.

Matches to Long-Term Acute Care Hospital (LTACH).

LTACHs specialize in weaning patients from prolonged mechanical ventilation and managing complex respiratory needs.

Evaluate the 81-year-old patient with deconditioning.

Matches to Skilled Nursing Facility (SNF).

SNFs provide skilled nursing (IV medications) and subacute rehabilitation for patients who cannot tolerate IRF intensity (can only tolerate 1 hour/day).

Evaluate the 89-year-old patient with cancer.

Matches to General Inpatient Hospice.

General inpatient hospice provides acute-level palliative care for refractory symptoms that exceed the capabilities of home caregivers.

Evaluate the 59-year-old patient with heart failure.

Matches to Home with Home Health Agency services.

Home Health provides part-time skilled nursing for homebound patients needing education and clinical assessment at their residence.

Key Concept

Criteria for Post-Acute Care Setting Transitions

Question 495Question →

A 68-year-old man with a history of severe chronic obstructive pulmonary disease (COPD) presents to the emergency department with a two-day history of progressively worsening shortness of breath, increased cough frequency, and a change in sputum from clear to thick, yellow-green. Vital signs show a temperature of 37.6°C (99.7°F), blood pressure of 138/86 mmHg, heart rate of 112/min, and respiratory rate of 26/min. Pulse oximetry is 88% on room air. Pulmonary examination reveals diffuse expiratory wheezing with a prolonged expiratory phase. Electrocardiogram shows sinus tachycardia. In addition to providing supplemental oxygen to maintain saturation between 88% and 92%, which of the following pharmacologic interventions are indicated for the initial management of this patient's acute exacerbation? (Select 3)

Select all that apply

Nebulized albuterol and ipratropium

Oral prednisone

Oral azithromycin

Intravenous metoprolol

Intravenous theophylline

Show answer & explanation

Answer: Nebulized albuterol and ipratropium; Oral prednisone; Oral azithromycin

Answer

The correct interventions are nebulized albuterol and ipratropium, oral prednisone, and oral azithromycin.

The acute management of a chronic obstructive pulmonary disease (COPD) exacerbation is based on three main pharmacologic pillars, especially when the patient presents with cardinal symptoms (increased dyspnea, increased sputum volume, and increased sputum purulence). First, short-acting bronchodilators (such as albuterol and ipratropium) are the mainstay of initial treatment to reverse acute bronchoconstriction. Second, systemic corticosteroids (such as oral prednisone) reduce airway inflammation, shorten recovery time, and decrease the risk of relapse. Third, antibiotics (such as azithromycin) are indicated because the presence of increased sputum purulence strongly suggests a bacterial trigger. Together, these three interventions effectively address the acute bronchospasm, underlying inflammation, and infectious precipitant.

Step-by-Step Solution

Diagnose the clinical syndrome.

The patient is experiencing an acute exacerbation of COPD.

Characterized by increased dyspnea, increased cough, and a change in sputum volume/purulence.

Select interventions to reverse airflow obstruction.

Identify short-acting bronchodilators (albuterol/ipratropium).

These agents provide rapid relief of acute bronchospasm.

Select interventions to treat underlying inflammation.

Identify systemic corticosteroids (prednisone).

A short course of systemic steroids improves lung function, oxygenation, and recovery time in severe exacerbations.

Evaluate the need for antimicrobial therapy.

Identify antibiotics (azithromycin).

The patient has cardinal symptoms including increased sputum purulence, which is a primary indication for empiric antibiotics to treat a likely bacterial trigger.

Key Concept

The standard triad of pharmacologic therapy for an acute COPD exacerbation with purulent sputum consists of short-acting bronchodilators, systemic corticosteroids, and empiric antibiotics.

Question 496Question →

A 45-year-old physician is reviewing protocols for the diagnostic workup of pulmonary embolism (PE) in the emergency department. Match each of the following patient clinical presentations with the most appropriate next step in their diagnostic evaluation.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The severe renal failure patient requires a V/Q scan. The hemodynamically unstable patient requires bedside echocardiography. The low clinical probability patient should receive a D-dimer assay. The stable, high clinical probability patient with normal renal function requires a CTPA.

Correct test sequencing requires triaging based on stability (unstable = bedside echo), then pretest probability (low = D-dimer rule out), and finally patient-specific contraindications (renal failure = V/Q scan instead of standard CTPA).

Step-by-Step Solution

Assess hemodynamic stability.

Patients with severe hypotension cannot be transported for imaging.

Transporting unstable patients risks cardiac arrest in unmonitored radiology settings. Bedside echocardiography is required to check for right heart strain.

Calculate clinical pretest probability for stable patients.

Identify if the patient has low, moderate, or high clinical probability (e.g., using Wells criteria).

Low probability patients should undergo D-dimer testing to potentially rule out PE without imaging, whereas high probability patients must proceed directly to imaging.

Evaluate contraindications to primary imaging modalities.

Check renal function (eGFR) and contrast allergy status.

CTPA is the standard imaging modality but requires iodinated contrast. Patients with severe chronic kidney disease should receive a V/Q scan instead to avoid contrast-induced nephropathy.

Key Concept

The diagnostic algorithm for suspected pulmonary embolism depends heavily on hemodynamic stability, pretest probability, and absolute contraindications to intravenous contrast.

Question 497Question →

A 34-year-old gravida 2, para 2 woman is evaluated in the labor and delivery unit due to sudden-onset severe dyspnea and altered mental status. She had an uncomplicated spontaneous vaginal delivery of a healthy neonate 30 minutes ago. On presentation, she is gasping for air and is lethargic. Blood pressure is 60/40 mm Hg, heart rate is 145/min, and respiratory rate is 34/min. Oxygen saturation is 76% on room air. Physical examination reveals generalized petechiae, profuse continuous bleeding from her peripheral intravenous catheter sites, and a soft, boggy uterus. Auscultation of the lungs reveals diffuse bilateral crackles. Which of the following are the most appropriate immediate steps in management? (Select 2)

Select all that apply

Endotracheal intubation and mechanical ventilation

Activation of the massive transfusion protocol

Administration of intravenous alteplase

Transfer for computed tomography pulmonary angiography

Transfer to interventional radiology for uterine artery embolization

Show answer & explanation

Answer: Endotracheal intubation and mechanical ventilation; Activation of the massive transfusion protocol

Answer

The most appropriate initial steps are endotracheal intubation with mechanical ventilation, and activation of the massive transfusion protocol.

The correct answers address the two most immediate life-threatening derangements in this patient. Endotracheal intubation is required because the patient is lethargic, severely hypoxemic, and unable to protect her airway. Activation of the massive transfusion protocol is required because the patient is in profound hemorrhagic shock complicated by disseminated intravascular coagulation, evidenced by diffuse bleeding from catheter sites.

Step-by-Step Solution

Analyze the clinical presentation.

The patient exhibits the classic triad of amniotic fluid embolism (AFE): sudden cardiovascular collapse, profound hypoxemia, and disseminated intravascular coagulation (DIC) occurring shortly after delivery.

Accurate syndrome recognition is required to direct immediate resuscitation efforts away from standard algorithms for simple pulmonary embolism or isolated uterine atony.

Address the patient's airway and breathing.

The correct intervention is endotracheal intubation and mechanical ventilation.

The patient has altered mental status, severe hypoxemia (76% on room air), and signs of cardiogenic/non-cardiogenic pulmonary edema (crackles). Securing the airway is the first priority in the ABC stabilization algorithm.

Address the patient's circulation and coagulopathy.

The correct intervention is the activation of the massive transfusion protocol.

The presence of petechiae and bleeding from intravenous sites indicates DIC, a hallmark of AFE. Severe hemorrhagic shock with coagulopathy must be aggressively managed with balanced blood products (packed red blood cells, fresh frozen plasma, and platelets).

Key Concept

The initial stabilization of amniotic fluid embolism (AFE) requires immediate adherence to the ABC algorithm, prioritizing endotracheal intubation for severe hypoxemia and massive transfusion protocol activation to manage profound hemorrhagic shock and consumptive coagulopathy.

Question 498Question →

A $46$ -year-old man comes to the clinic for evaluation of a $6$ -month history of persistent, burning epigastric pain and voluminous, watery diarrhea. He reports no weight loss, hematemesis, or melena. Two months ago, an esophagogastroduodenoscopy performed at an outside facility showed prominent gastric folds and multiple ulcerations in the duodenal bulb and postbulbar duodenum. He was prescribed high-dose pantoprazole, which initially provided partial relief, but his symptoms recurred. He was instructed to discontinue pantoprazole $14$ days prior to today's visit. Vital signs are within normal limits. Physical examination reveals mild epigastric tenderness but is otherwise unremarkable.

Laboratory studies show:
Serum calcium: $9.2$ mg/dL
Serum creatinine: $0.9$ mg/dL
Fasting serum gastrin: $680$ pg/mL (Normal: $< 100$ pg/mL)

A nasogastric tube is placed, and gastric fluid analysis reveals a basal acid output of $22$ mEq/h (Normal: $< 10$ mEq/h) and a gastric fluid pH of $1.5$ .

Which of the following is the most appropriate next step in the diagnostic workup?

Secretin stimulation test

Gallium-68 DOTATATE PET/CT scan

Endoscopic ultrasound of the pancreas

Measurement of anti-parietal cell antibodies

Genetic testing for MEN1 gene mutations

Show answer & explanation

Answer: Secretin stimulation test

Answer

The correct answer is the secretin stimulation test.

The correct sequence of diagnostic testing is to perform a secretin stimulation test. The patient presents with clinical features highly suggestive of Zollinger-Ellison syndrome (ZES). While his fasting serum gastrin is elevated (

680

pg/mL) and his gastric pH is appropriately low (

1.5

, ruling out achlorhydria), a fasting gastrin level is only definitively diagnostic of ZES if it is greater than

10

times the upper limit of normal (typically

> 1000

pg/mL). For values in the equivocal range (

100-1000

pg/mL), biochemical confirmation is required using the secretin stimulation test. Secretin normally inhibits gastrin release from normal gastric G cells but paradoxically stimulates gastrin release from gastrinoma cells.

Step-by-Step Solution

Analyze the clinical presentation and initial endoscopy.

The patient has refractory peptic ulcer disease in atypical locations (postbulbar duodenum), prominent gastric folds, and diarrhea, which are classic signs of Zollinger-Ellison syndrome (ZES).

Identifying the clinical syndrome guides the selection of the appropriate biochemical workup.

Interpret the laboratory and gastric fluid analyses.

The fasting serum gastrin is elevated at

680

pg/mL. The gastric pH is

< 2.0

(

1.5

), which confirms primary hyperchlorhydria and rules out secondary hypergastrinemia caused by achlorhydria.

Differentiating between primary hypersecretion (gastrinoma, retained antrum) and secondary hypersecretion (atrophic gastritis, PPI use) is the critical first diagnostic branch point.

Evaluate the fasting gastrin level against diagnostic thresholds.

A fasting gastrin level

> 1000

pg/mL combined with a gastric pH

< 2.0

is definitively diagnostic of ZES. However, this patient's level of

680

pg/mL falls into the equivocal range (

100

1000

pg/mL).

Recognizing that the laboratory values are highly suspicious but not definitively diagnostic dictates the need for further biochemical confirmation rather than proceeding immediately to imaging.

Select the correct confirmatory test sequence.

The secretin stimulation test must be performed. A rise in serum gastrin of

> 120

pg/mL above basal levels following secretin administration will definitively confirm the diagnosis of ZES.

Proper test sequencing dictates that biochemical confirmation must be absolutely secured prior to ordering expensive, high-radiation, or invasive localizing imaging.

Key Concept

In patients with suspected Zollinger-Ellison syndrome who have a gastric pH

< 2.0

but an equivocal fasting serum gastrin level (

100

1000

pg/mL), the diagnosis must be biochemically confirmed using a secretin stimulation test before proceeding to tumor localization imaging.

Question 499Question →

A 32-year-old woman is brought to the emergency department via ambulance due to a witnessed generalized tonic-clonic seizure. Her partner reports that she has no history of seizures but complained of a severe headache earlier today. Paramedics report the seizure began $15$ minutes ago and has been continuous since their arrival. On presentation, she is unresponsive, actively convulsing with rhythmic extremity jerking, and frothing at the mouth. Vitals are temperature $37.6^\circ\text{C}$ ( $99.7^\circ\text{F}$ ), pulse $135$ /min, blood pressure $158/92$ mmHg, and oxygen saturation $92\%$ on a non-rebreather mask. Intravenous access is established.

Arrange the following pharmacologic interventions in the most appropriate chronological sequence for the stepwise management of this patient's condition, from first-line therapy to treatments reserved for super-refractory disease.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing status epilepticus begins with a rapid-acting benzodiazepine (intravenous lorazepam), followed by a long-acting antiseizure medication (intravenous fosphenytoin), escalated to an anesthetic infusion (intravenous propofol) for refractory cases, and finally a barbiturate coma (intravenous pentobarbital) for super-refractory status.

Status epilepticus is defined as

\ge 5

minutes of continuous clinical seizure activity or recurrent seizures without return to baseline. It requires a rigid, stepwise pharmacologic approach. Phase I (first-line) utilizes rapid-acting benzodiazepines (intravenous lorazepam, or intramuscular midazolam if IV access is unavailable) to immediately halt the seizure. Phase II (second-line) employs long-acting antiseizure medications (intravenous fosphenytoin, valproic acid, or levetiracetam) to prevent recurrence or treat established status. Phase III (third-line) involves anesthetic infusions (propofol or midazolam) for refractory status epilepticus, which necessitates endotracheal intubation. Finally, if the patient remains in super-refractory status epilepticus, a barbiturate coma using pentobarbital is initiated.

Step-by-Step Solution

Identify the clinical emergency and immediate goal.

The patient is in generalized convulsive status epilepticus (continuous seizure > 5 minutes).

This is a neurologic emergency requiring immediate protocolized pharmacologic escalation to prevent irreversible neuronal injury and excitotoxicity.

Select the optimal first-line abortive therapy.

Intravenous lorazepam is selected as the initial intervention.

Highly lipid-soluble benzodiazepines cross the blood-brain barrier rapidly to terminate ongoing clinical seizures immediately.

Select the appropriate second-line therapy.

Intravenous fosphenytoin is selected next.

Regardless of whether the seizure stops after the benzodiazepine, a long-acting agent is required to prevent recurrence. If the seizure persists, it serves as the next abortive step.

Determine the third-line therapy for refractory status epilepticus.

Intravenous propofol is selected for step three.

When standard non-sedating agents fail, continuous anesthetic infusions (propofol or midazolam) are required. This step simultaneously requires definitive airway management (intubation).

Identify the final intervention for super-refractory status.

Intravenous pentobarbital is placed last.

Barbiturate coma is highly suppressive to both the cortex and the cardiovascular system, making it the intervention of absolute last resort when all other therapies fail.

Key Concept

Pharmacologic escalation algorithm for Status Epilepticus

Question 500Question →

A 31-year-old woman with a 5-year history of highly active relapsing-remitting multiple sclerosis is evaluated in the clinic. She has experienced recurrent clinical exacerbations, and a recent magnetic resonance imaging study of the brain and spine reveals multiple new gadolinium-enhancing lesions despite excellent adherence to sequential trials of dimethyl fumarate and natalizumab. After a comprehensive discussion of risks and benefits, she is transitioned to alemtuzumab. She completes baseline screening, receives prophylactic antiviral therapy, and finishes her first 5-day intravenous infusion course without severe acute infusion reactions. Prior to discharge, the physician must implement a strict, long-term monitoring protocol as mandated by the drug's Risk Evaluation and Mitigation Strategy (REMS) program to detect delayed, potentially life-threatening complications. Which of the following longitudinal monitoring parameters are strictly required for up to 48 months following her last infusion of this medication? (Select all that apply)

Select all that apply

Monthly complete blood count with differential

Monthly serum creatinine and urinalysis with microscopy

Quarterly thyroid-stimulating hormone evaluation

Serial echocardiography every 6 months to assess left ventricular ejection fraction

Annual comprehensive ophthalmoscopy with optical coherence tomography

Monthly flow cytometry for CD4+ T-lymphocyte counts

Show answer & explanation

Answer: Monthly complete blood count with differential; Monthly serum creatinine and urinalysis with microscopy; Quarterly thyroid-stimulating hormone evaluation

Answer

The strictly required monitoring parameters for up to 48 months following alemtuzumab infusion are a monthly complete blood count with differential, monthly serum creatinine and urinalysis with microscopy, and a quarterly thyroid-stimulating hormone evaluation.

Alemtuzumab is a highly efficacious disease-modifying therapy for multiple sclerosis that functions by depleting CD52-expressing T and B lymphocytes. As the immune system reconstitutes over time, patients are at a severe, life-threatening risk of developing secondary autoimmune disorders. Because these conditions can manifest up to 4 years after the last dose, the FDA mandates a strict Risk Evaluation and Mitigation Strategy (REMS). This protocol explicitly requires monthly complete blood counts with differential to screen for immune thrombocytopenic purpura (ITP), monthly serum creatinine and urinalysis with microscopy to detect anti-glomerular basement membrane (anti-GBM) disease, and quarterly (every 3 months) thyroid-stimulating hormone (TSH) testing to monitor for autoimmune thyroid disorders. All three of these parameters must be tracked for 48 months following the last infusion.

Step-by-Step Solution

Identify the prescribed pharmacotherapy and its mechanism of action.

The patient is receiving alemtuzumab, a humanized monoclonal antibody targeting CD52, which causes profound and prolonged depletion of T and B lymphocytes.

Understanding the mechanism of action is essential to predicting the unique adverse effect profile during the immune reconstitution phase.

Determine the specific delayed adverse effects associated with this medication.

Alemtuzumab carries a significant risk for secondary autoimmune conditions, most notably immune thrombocytopenic purpura (ITP), anti-glomerular basement membrane (anti-GBM) disease, and autoimmune thyroiditis.

These complications can be fatal if not detected early, often presenting months to years after the final drug administration.

Apply the mandated Risk Evaluation and Mitigation Strategy (REMS) protocol guidelines for this high-risk medication.

The REMS program requires monthly blood counts (for ITP), monthly renal panels with urinalysis (for anti-GBM), and quarterly TSH testing (for thyroid disease) continuing for 48 months after the last dose.

Selecting the exact required intervals differentiates protocol-driven monitoring from standard periodic lab checks.

Key Concept

Alemtuzumab requires stringent, protocolized monitoring for up to 48 months post-infusion to detect secondary autoimmune complications: monthly CBC (for ITP), monthly urinalysis/creatinine (for anti-GBM disease), and quarterly TSH (for thyroiditis).

Estimated Time:2m 0s

PreviousPage 25 / 104Next

Patient Management

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept